Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Share-Based Payment Transactions (Tables)

v3.23.1
Share-Based Payment Transactions (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of expenses
    Year ended December 31,  
    2022     2021     2020  
                   
Research and development expenses   $ 137     $ 200     $ 159  
General and administrative expenses     126       266       158  
      263       466       317  

 
Schedule of estimated using the binomial option pricing model
Description   2022     2021     2020  
                   
Risk-free interest rate     1.41%-3.08%       1.22-1.28%       0.93-2.40%  
Expected volatility     83.98%-84.26%        82.40-82.43%       65.63-78.77%  
Dividend yield     0       0       0  
Contractual life     10       10       9.83 - 10  
Early Exercise Multiple (Suboptimal Factor)     2.5-3       3       2.5 - 3  
Exercise price (NIS)     0.25       0.25-0.253       0.25 - 2.344  

 
Schedule of share options, their weighted average exercise price
    Number of
options		     Weighted
average
exercise
price		     Weighted
average
remaining
contractual
terms (in years)		     Aggregate
intrinsic
value		  
                         
Outstanding at December 31, 20221     18,422,700       0.18       8.45      
      -
  
Grants     8,750,000       0.07      
 
      
 
  
Forfeited/expired     (170,500 )     0.54      
-
      
 
  
                                 
Outstanding at December 31, 2022     27,002,200       0.13       7.14      
-
  
                                 
Vested and expected to vest at December 31, 2022     27,002,200       0.13       7.14      
-
  
                                 
Exercisable at December 31, 2022     11,071,575       0.21       7.18      
-